These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 22374761
21. A clinican's guide to adult attention-deficit hyperactivity disorder. Modesto-Lowe V, Meyer A, Soovajian V. Conn Med; 2012 Oct; 76(9):517-23. PubMed ID: 23155670 [Abstract] [Full Text] [Related]
22. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. Najib J. Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715 [Abstract] [Full Text] [Related]
23. ADHD in adults: a review of the literature. Davidson MA. J Atten Disord; 2008 May; 11(6):628-41. PubMed ID: 18094324 [Abstract] [Full Text] [Related]
24. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
25. Adults with attention deficit hyperactivity disorder: assessment and treatment considerations. Murphy K. Semin Speech Lang; 1996 Aug; 17(3):245-53; quiz 254. PubMed ID: 8912439 [Abstract] [Full Text] [Related]
26. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF, Miller A, Fine S. Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [Abstract] [Full Text] [Related]
27. The consequences of attention-deficit/hyperactivity disorder in adults. Goodman DW. J Psychiatr Pract; 2007 Sep; 13(5):318-27. PubMed ID: 17890980 [Abstract] [Full Text] [Related]
28. [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]. Ludolph AG, Kölch M, Plener PL, Schulze UM, Spröber N, Fegert JM. Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):405-11. PubMed ID: 19739058 [Abstract] [Full Text] [Related]
29. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900 [Abstract] [Full Text] [Related]
38. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Weibel S, Menard O, Ionita A, Boumendjel M, Cabelguen C, Kraemer C, Micoulaud-Franchi JA, Bioulac S, Perroud N, Sauvaget A, Carton L, Gachet M, Lopez R. Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922 [Abstract] [Full Text] [Related]